pharmacovigilance

Pharmacovigilance

Patient Safety at Novartis India Limited

At Novartis India Limited, patient safety is our highest priority. We are committed to monitoring the safety, quality, and effectiveness of our products throughout their lifecycle.

Pharmacovigilance is the science and activity relating to the detection, assessment, understanding, and prevention of adverse effects or any other medicine-related problems. Through our pharmacovigilance program, we continuously monitor safety information to help ensure the appropriate use of our products and contribute to patient well-being.

What Should Be Reported?

We encourage healthcare professionals, patients, caregivers, distributors, and business partners to report:

a

Adverse Events
(Side Effects)

b

Serious Adverse Events

c

Medication Errors

d

Lack of Efficacy

e

Product Quality Complaints

f

Product Misuse or Abuse

g

Overdose Cases

i

Pregnancy and Lactation Exposure Cases

j

Unexpected Safety Concerns

How to Report an Adverse Event

If you become aware of an adverse event or any safety-related information associated with an/ any Novartis India Limited product, please contact our Pharmacovigilance Team promptly.

Contact Details

Pharmacovigilance Department, Novartis India Limited

Information Helpful for Reporting

When reporting an adverse event, please provide, where available:

Reports may also be submitted by healthcare professionals, patients, caregivers, distributors, or other stakeholders.

confidentiality

Confidentiality

Novartis India Limited respects the privacy of patients and reporters. Personal information provided during adverse event reporting will be processed in accordance with applicable data protection and pharmacovigilance requirements and used solely for patient safety monitoring purposes.

Commitment to Patient Safety

Novartis India Limited remains committed to maintaining the highest standards of pharmacovigilance and regulatory compliance
to support the safe and effective use of its products.